Visit COVID-19 resources

[Skip to Content]

Comparison of vascular endothelial growth factor inhibitors on macular oedema secondary central retinal vein occlusion – (Eye Journal)

Nov 26
2019

Eye, Published online: 26 November 2019; doi:10.1038/s41433-019-0707-5 Comparison of vascular endothelial growth factor inhibitors on macular oedema secondary central retinal vein occlusion

  • 26 November 2019

Prevalence and risk factors of childhood blepharoptosis in Koreans: the Korea National Health and Nutrition Examination Survey – (Eye Journal)

Nov 26
2019

Eye, Published online: 26 November 2019; doi:10.1038/s41433-019-0697-3 Prevalence and risk factors of childhood blepharoptosis in Koreans: the Korea National Health and Nutrition Examination Survey

  • 26 November 2019

Home monitoring for glaucoma – (Eye Journal)

Nov 26
2019

Eye, Published online: 26 November 2019; doi:10.1038/s41433-019-0669-7 Home monitoring for glaucoma

  • 26 November 2019

Patient-reported outcomes measures and patient preferences for minimally invasive glaucoma surgical devices – (Eye Journal)

Nov 26
2019

Eye, Published online: 26 November 2019; doi:10.1038/s41433-019-0676-8 Patient-reported outcomes measures and patient preferences for minimally invasive glaucoma surgical devices

  • 26 November 2019

Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose? – (Eye Journal)

Nov 26
2019

Eye, Published online: 26 November 2019; doi:10.1038/s41433-019-0706-6 Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose?

  • 26 November 2019